blindness with semaglutide Could Ozempic and Wegovy Be Linked to Blindness? Over a dozen lawsuits claim

Week: 56: optimizing weight loss Your healthcare provider may move you to the next dose increment (usually 0.5 mg) around week five

Jason Wersland reveals how mastering your heart rate variability and internal chemistry can unlock a new level of longevity

Compounded formulations are not FDA-approved in the same way brand products are, though they may be prepared in FDA-compliant facilities

His work focuses on how microbial ecosystems interact with human physiology, including: Gut barrier function and intestinal permeability Mucus-associated microbiota (Akkermansia-related systems) Oralgut microbiome axis Short-chain fatty acids (SCFAs) and metabolic signaling Circadian rhythmmicrobiome interactions Clinical Research Contributions He has contributed to multiple clinical-stage microbiome programs, supporting bacterial strain discovery, optimization, and formulation design across different therapeutic areas, including: Active Ulcerative Colitis (Inflammatory Bowel Disease) Hyperoxaluria (Oxalate Metabolism Disorder) Microbiome-driven gut health and inflammatory conditions These studies were part of broader clinical development programs evaluating microbiome-based approaches